Sulunz has every right to complain. She's held BIT for a longtime and she's had a fairly sizeable holding. A shareholder has every right to go through doubt and self-questioning. This is the game.
Non-holders though (or those pretending to hold with a doubtful disclosure of 'held')? No. Also those who are directors of another biotech company. The conflict of interest bell is ringing loudly for those.
This is speculative biotech. Keywords are 'speculative' and 'biotech'.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-32
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
